Search - tctmd.com

Displaying 281 - 296 of 296

Sort: Relevancy | Date

News Conference News AHA 2016

No CV Safety Differences for COX-2 Inhibitor vs Other NSAIDs in PRECISION

Shelley Wood

November 13, 2016

News Daily News

社会经济地位可能会影响男性他汀类药物的依从性，女性结果不明

Yael L. Maxwell

October 25, 2016

News Daily News

Socioeconomic Standing May Affect Statin Adherence in Men, With Unclear Consequences in Women

Yael L. Maxwell

October 25, 2016

News Daily News

La Situación Socioeconómica podría Afectar a la Adherencia a las Estatinas en Hombres, Con Consecuencias Poco Claras en Mujeres

Yael L. Maxwell

October 25, 2016

News Daily News

Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies

Michael O'Riordan

September 27, 2016

News Daily News

Low-Dose NOACs Top Warfarin in Asian Patients in Everyday Practice, Retrospective Study Suggests

Todd Neale

September 26, 2016

News Conference News ESC 2016

Ezetimibe Plus Pitavastatin Fails to Lower Risk of CVD Events in ACS Patients: HIJ-PROPER

Michael O'Riordan

August 30, 2016

News Daily News

Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings

Michael O'Riordan

July 12, 2016

News Daily News

Adherence to Guideline-Based Acute MI Therapies Has Prolonged Impact on Mortality Rates

Michael O'Riordan

May 17, 2016

News Daily News

USPSTF Tightens Up Primary-Prevention Recommendations, Saying Aspirin Should Be Used Only in High-Risk Individuals

Michael O'Riordan

April 12, 2016

News Daily News

New Analysis of COGENT Supports PPI Use in Patients on Low-Dose Aspirin

Caitlin E. Cox

March 23, 2016

News Conference News AHA 2015

Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding

Todd Neale

November 10, 2015

News Daily News

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

April 29, 2015

News Daily News

ITALIC Published: No Benefit to Long-Term DAPT After Stenting

Yael L. Maxwell

March 10, 2015

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

News Daily News

JUPITER: Rosuvastatin Cuts Heart Risk, Even In LDL-Normal Patients

November 11, 2008

Advertisement

No CV Safety Differences for COX-2 Inhibitor vs Other NSAIDs in PRECISION

社会经济地位可能会影响男性他汀类药物的依从性，女性结果不明

Socioeconomic Standing May Affect Statin Adherence in Men, With Unclear Consequences in Women

La Situación Socioeconómica podría Afectar a la Adherencia a las Estatinas en Hombres, Con Consecuencias Poco Claras en Mujeres

Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies

Low-Dose NOACs Top Warfarin in Asian Patients in Everyday Practice, Retrospective Study Suggests

Ezetimibe Plus Pitavastatin Fails to Lower Risk of CVD Events in ACS Patients: HIJ-PROPER

Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings

Adherence to Guideline-Based Acute MI Therapies Has Prolonged Impact on Mortality Rates

USPSTF Tightens Up Primary-Prevention Recommendations, Saying Aspirin Should Be Used Only in High-Risk Individuals

New Analysis of COGENT Supports PPI Use in Patients on Low-Dose Aspirin

Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

ITALIC Published: No Benefit to Long-Term DAPT After Stenting

Cilostazol Reduces Repeat Revascularizations for Long Lesions

JUPITER: Rosuvastatin Cuts Heart Risk, Even In LDL-Normal Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content